News | Mammography | April 03, 2024

The market leader in Operational AI solutions will showcase its new GPT AI solution at the upcoming SBI symposium in Montreal

The market leader in Operational AI solutions will showcase its new GPT AI solution at the upcoming SBI symposium in Montreal

April 3, 2024 — Densitas, a global leader in artificial intelligence solutions for breast cancer screening, announces the commercial release of intelliMaven, a groundbreaking GPT AI assistant for mammography quality. Together with Densitas’ flagship product intelliMammo, intelliMaven provides scalable and sustainable quality assurance for mammography facilities to meet FDA MQSA EQUIP compliance and ACR accreditation requirements.

In an industry-first move, Densitas is revolutionizing the way technologists master their craft. intelliMaven offers bespoke recommendations that align with each technologist's individual learning journey and training needs. This personalized feedback not only accelerates the skill enhancement process but also ensures technologists can refine their positioning techniques with unprecedented efficiency to improve diagnostic accuracy and the standard of patient care.

intelliMaven is designed to support sustainable high-value mammography service delivery at scale by streamlining workflows and fostering a culture of confidence and autonomy among technologists, unlocking new operational efficiencies with expert feedback in real time.

“IntelliMaven is a game-changer. Access to synchronous feedback based on continuous data collection sharpens technologists’ decision-making skills, allowing them greater independence and autonomy, therefore diminishing interruptions for radiologists,” said Dr. Georgia Spear, Chief Breast Imaging at Endeavor Health (Chicago, IL). “Its proficiency in analyzing complex data and summarizing it clearly and succinctly is truly remarkable. This ensures impartial and effective performance reviews. This software doesn’t just add value to daily operations; it redefines them.”

As mammography practices worldwide face an unprecedented staffing crisis, excessive workloads, and alarming burnout rates among technologists and radiologists, intelliMaven is poised to elevate mammography quality standards to:

● Save Time: by transforming complex data into actionable insights swiftly and in easily understood narrative reports, allowing care teams to prioritize patient care and other high-value activities.

● Optimize Radiologists’ Reading Efficiency: by offering immediate and continuous feedback to technologists regarding their performance, and shielding radiologists from frequent interruptions while reading mammograms.

● Mitigate Burnout: by reducing cognitive fatigue and easing decision-making pressures through the automation of data analysis and interpretation, and delivering real-time results and feedback in narrative language.

intelliMaven provides personalized, data-driven training guidance for technologists, paired with expert advice for ongoing skill enhancement in mammography techniques. It also delivers objective, standardized feedback to empower technologists, fostering greater ownership and autonomy in their roles and enhancing job satisfaction.

Discover how intelliMaven can transform your mammography practice at SBI Booth #415. Priority will be given to pre-booked demos. Book yours at https://densitashealth.com/sbi-2024/

For more information: www.densitashealth.com

 

Find more SBI24 conference coverage here


Related Content

News | Stroke

March 11, 2026 — Brainomix, a provider of AI-powered imaging tools for stroke and lung fibrosis, has announced the ...

Time March 11, 2026
arrow
News | HIMSS

March 9, 2026 — Fujifilm Healthcare Americas Corp. is showcasing how its latest AI-powered enterprise imaging solutions ...

Time March 10, 2026
arrow
News | HIMSS

March 5, 2026 — At the Health Information and Management Systems Society (HIMSS) Conference & Exhibition 2026 in Las ...

Time March 06, 2026
arrow
News | Women's Health

March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the ...

Time March 06, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Ultrasound Women's Health

March 2, 2026 — Ultrasound AI, a provider of artificial intelligence applications for medical imaging, has received FDA ...

Time March 03, 2026
arrow
News | FDA

Feb. 26, 2026 — The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the ...

Time February 26, 2026
arrow
News | Ultrasound Imaging

Feb. 25, 2026 — GE HealthCare is introducing the next generation of LOGIQ general imaging ultrasound systems – an ...

Time February 25, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
Subscribe Now